Home / Stock ratings / A
Stock rating · Laboratory Analytical Instruments
Agilent Technologies Inc. (A) Stock Rating & Analysis
As of October 13, 2026, MELANY rates Agilent Technologies Inc. 61 out of 100 (Hold). Its highest factor score is price momentum at 79, and its lowest is valuation at 39.
MELANY ratingRated 2026-10-13A · composite score
About Agilent Technologies Inc.
Agilent, originally spun out of Hewlett-Packard in 1999, has become a leading life science and diagnostics company. Its measurement technologies serve a broad customer base through three operating segments: life science and diagnostics; cross lab operations, consisting of consumables and services; and applied end markets.
Rating as of 2026-10-13 · this is a dated snapshot; the live rating is in the app (Pro, free for 30 days). The price above updates in real time.
Why A scores 61/100
A's 8 factor scores run from 39 to 79, and 4 of them sit above its composite of 61. Here is how A breaks down.
Whether the price looks cheap or expensive against earnings, growth, and peers.
Margins, returns on capital, and balance-sheet strength.
- Gross margin 53%
- ROE 21%
Direction and relative strength of the recent share-price trend.
- Price +9.7% above 50-day MA
- 50-day MA above 200-day (golden cross zone)
History of beating or missing estimates, and where estimates are heading.
What Wall Street price targets and revisions are signalling.
Near-term events that could move the stock.
Upside weighed against volatility and drawdown risk.
How the current rate and market regime suits this kind of company.
How A compares
As of October 13, 2026, Agilent Technologies Inc. ranks 2nd of the 4 companies with a MELANY rating page in its SEC industry group (Laboratory Analytical Instruments), where the average score is 63.
Key risks for A
- Trading near 52-week high, limited upside without new positive catalyst
Sector and theme context
Agilent Technologies Inc. sits in the Healthcare sector theme, which MELANY currently rates 61/100 for strength. Theme strength feeds A's momentum and catalyst factors above.
Tracking A
Agilent Technologies Inc. rates Hold right now, so MELANY is not flagging a fresh entry. Add A to a watchlist in the app to follow its rating; an alert the moment it changes is part of Pro, free for 30 days.
How MELANY rates A
MELANY is a rules-based engine that scores every stock from 0 to 100 across eight weighted factors, then re-scores as new price, earnings, and fundamental data arrive. Agilent Technologies Inc.'s 61/100 reflects mature factor weighting for its profile.
Ratings are algorithmic and change with the data. They are research and education, not personalized investment advice.
Frequently asked questions about A
Is Agilent Technologies Inc. (A) a buy?
As of 2026-10-13, MELANY rated Agilent Technologies Inc. Hold with a composite score of 61/100. That is a dated snapshot, not the live rating, and it is an algorithmic reading built from eight factors rather than personalized investment advice. Review the factor breakdown above and the disclaimer below before making any decision.
What is Agilent Technologies Inc.'s MELANY score?
Agilent Technologies Inc. (A) has a MELANY composite score of 61/100, combining valuation, business quality, price momentum, earnings track record, analyst sentiment, catalyst setup, risk-adjusted profile, macro fit.
How is the A stock rating calculated?
MELANY scores A from 0 to 100 across eight weighted factors using live market and fundamental data, then refreshes the rating automatically as new data arrives.
Should I buy Agilent Technologies Inc. stock?
That decision is yours; Market Eyes Live does not give buy or sell advice. What the data says: MELANY rates Agilent Technologies Inc. (A) Hold with a composite of 61/100 as of 2026-10-13. The factor breakdown above shows what is driving that, which is a better basis for a decision than any one-word verdict.
What is the A stock price forecast?
MELANY does not publish price targets or forecasts for A. Predicting a future price is exactly the kind of false precision the confidence framework avoids. Instead it scores today's setup, 61/100 across eight factors for Agilent Technologies Inc., and re-scores automatically as new price, earnings, and fundamental data arrive.
Is A stock overvalued or undervalued?
MELANY's valuation factor currently reads 39/100 for Agilent Technologies Inc., where a higher score means the price looks more attractive on that measure. Scores in the 70s and above read as attractively priced, the mid range as roughly fair, and low scores as stretched. The factor breakdown above shows what drives A's read.
What price should I buy A at?
MELANY is not flagging a fresh entry for A at its current Hold rating, so there is no entry zone to publish right now. Add A to a watchlist in the app to follow it; an alert the moment the rating changes is part of Pro, free for 30 days.
What are the risks of buying A stock?
The top risks MELANY currently flags for Agilent Technologies Inc.: Trading near 52-week high, limited upside without new positive catalyst. The rating on this page already weighs these against the bullish factors; see the risk-adjusted profile score in the breakdown above.
Is Agilent Technologies Inc. a good long-term investment?
For long-term durability the two factors that matter most are business quality, which MELANY scores 71/100 for Agilent Technologies Inc., and earnings track record, at 61/100. The 61/100 composite blends those with six shorter-horizon factors. Durable quality at a fair price is the long-term case to test; this is research, not personalized investment advice.
Will A stock go up?
Nobody can promise a stock's direction, and Market Eyes Live does not predict prices. The measurable part: MELANY's price momentum factor reads 79/100 for A right now, and the catalyst setup factor tracks whether near-term events could move it. Both re-score automatically as the data changes.
How current is this A rating?
The rating on this page is a snapshot of MELANY's read as of 2026-10-13. The price shown updates live, but the score is not recomputed on this page. MELANY re-scores A continuously as new price, earnings, and fundamental data arrive, and the current rating is in the app (Pro, free for 30 days).
How this rating works
Market Eyes Live
Every rating graded in public, A included
MELANY scores more than 11,000 U.S. stocks and ETFs, PRISM ranks conviction and APEX writes the plan with one entry zone. Free to start on iOS and the web.